SCHEMBL472300

SCHEMBL472300

C=Cc1ccc2cc(C(=O)OC3CN(COC)C(=O)N(COC)C3)ccc2c1

nearest known ligand 0.33

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM2B Q8NHM5 3/20 0.31
HRH3 Q9Y5N1 1/20 0.31
LGALS9 O00182 1/20 0.30
LGALS8 O00214 1/20 0.30
LGALS1 P09382 1/20 0.30
LGALS3 P17931 1/20 0.30
LGALS7; LGALS7B P47929 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10021861 0.98 ALDH1A1 (0.32) CYP2D6ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10021857 0.98 ALDH1A1 (0.32) CYP2D6ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10021856 0.97 CYP2D6 (0.32) CYP2D6ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10053096 0.96 KDM2B (0.32) CYP2D6ALDH1A1KMT2AMEN1KDM2B
SCHEMBL471779 0.89 SMN1; SMN2 (0.38) CYP2D6ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10021858 0.87 ALDH1A1 (0.38) ALDH1A1KMT2AMEN1
SCHEMBL10053102 0.85 TAS1R3 (0.35) KMT2AMEN1SMN1; SMN2
SCHEMBL10021864 0.83 ALDH1A1 (0.33) ALDH1A1KMT2AMEN1HRH3LGALS9
SCHEMBL10021863 0.82 KDM2B (0.33) CYP2D6ALDH1A1KMT2AMEN1KDM2B
SCHEMBL10021859 0.80 MEN1 (0.32) CYP2D6ALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2413192-B1 POLYMERIZABLE MONOMERS SHINETSU CHEMICAL CO (JP) 2016-12-21 EP disclosed
EP-2412733-B1 Polymer, chemically amplified negative resist composition, and patterning process SHINETSU CHEMICAL CO (JP) 2016-03-23 EP disclosed
EP-2412733-B1 Polymer, chemically amplified negative resist composition, and patterning process SHINETSU CHEMICAL CO (JP) 2016-03-23 EP disclosed
US-8501942-B2 Polymerizable monomers SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-08-06 US disclosed
US-8501942-B2 Polymerizable monomers SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-08-06 US disclosed
US-8470512-B2 Polymer, chemically amplified negative resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-06-25 US disclosed
US-8470512-B2 Polymer, chemically amplified negative resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-06-25 US disclosed
US-20120028190-A1 POLYMER, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-02-02 US disclosed
US-20120028190-A1 POLYMER, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-02-02 US disclosed
US-20120029193-A1 POLYMERIZABLE MONOMERS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-02-02 US disclosed
US-20120029193-A1 POLYMERIZABLE MONOMERS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-02-02 US disclosed
EP-2413192-A1 Polymerizable monomers Shin-Etsu Chemical Co., Ltd. (JP) 2012-02-01 EP disclosed
EP-2412733-A1 Polymer, chemically amplified negative resist composition, and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2012-02-01 EP disclosed
EP-2412733-A1 Polymer, chemically amplified negative resist composition, and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2012-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029193-A1 POLYMERIZABLE MONOMERS C9, CCNA1, H1-0 CYP2D6 2072/4885ALDH1A1 619/4885KMT2A 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.